Cargando…

ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women

BACKGROUND: The aim of this study was to ascertain the magnitude of association of gene ТР53 Arg72Pro polymorphic marker with cervical cancer (CC) in Kyrgyz women. METHODS: We identified and included 205 women of Kyrgyz ethnicity for this case-control study, of whom N=103 were women (mean age 53.5 ±...

Descripción completa

Detalles Bibliográficos
Autores principales: Isakova, Jainagul, Vinnikov, Denis, Bukuev, Nurbek, Talaibekova, Elnura, Aldasheva, Nazira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948899/
https://www.ncbi.nlm.nih.gov/pubmed/31030474
http://dx.doi.org/10.31557/APJCP.2019.20.4.1057
_version_ 1783485820967059456
author Isakova, Jainagul
Vinnikov, Denis
Bukuev, Nurbek
Talaibekova, Elnura
Aldasheva, Nazira
author_facet Isakova, Jainagul
Vinnikov, Denis
Bukuev, Nurbek
Talaibekova, Elnura
Aldasheva, Nazira
author_sort Isakova, Jainagul
collection PubMed
description BACKGROUND: The aim of this study was to ascertain the magnitude of association of gene ТР53 Arg72Pro polymorphic marker with cervical cancer (CC) in Kyrgyz women. METHODS: We identified and included 205 women of Kyrgyz ethnicity for this case-control study, of whom N=103 were women (mean age 53.5 ± 10.0 years) with histologically confirmed CC and N=102 controls (mean age 46.5 ± 8.5 years). We detected human papilloma virus (HPV) DNA types 16 and 18 using polymerase chain reaction (PCR) with hybridization/fluorescent detection. Genotypes of ТР53 gene Arg72Pro polymorphism were identified using PCR-RFLP assay. RESULTS: Eighty-eight percent (90/103) women with CC had HPV, of whom 43.4% (39/90) had HPV type 16, 24.4% (22/90) had HPV type 18, whereas 32.2% (29/90) carried both types. The univariate analysis of allele and genotype distribution of Arg72Pro polymorphic marker of ТР53 gene showed no difference between CC and control groups (χ(2)=1.24, р=0.54). However, when CC cases associated with HPV were tested against controls, Arg72 allele and Arg72Arg genotype prevalence were greater compared to controls (χ²=7.25; р=0.027 for genotypes and χ²=6.83; р=0.009 for alleles). In HPV-positive women, Arg72Arg genotype of ТР53 gene was associated with a 1.85-fold increase in the likelihood of CC (OR=1.85 [95% confidence interval (CI) 1.03-3.32]), whereas Arg72 allele increased this likelihood 1.94-fold (OR=1.94 [95% CI 1.20-3.15]). CONCLUSIONS: Arg72Arg genotype and Arg72 allele of ТР53 gene in Kyrgyz women increase the risk of HPV-associated CC.
format Online
Article
Text
id pubmed-6948899
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-69488992020-02-04 ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women Isakova, Jainagul Vinnikov, Denis Bukuev, Nurbek Talaibekova, Elnura Aldasheva, Nazira Asian Pac J Cancer Prev Research Article BACKGROUND: The aim of this study was to ascertain the magnitude of association of gene ТР53 Arg72Pro polymorphic marker with cervical cancer (CC) in Kyrgyz women. METHODS: We identified and included 205 women of Kyrgyz ethnicity for this case-control study, of whom N=103 were women (mean age 53.5 ± 10.0 years) with histologically confirmed CC and N=102 controls (mean age 46.5 ± 8.5 years). We detected human papilloma virus (HPV) DNA types 16 and 18 using polymerase chain reaction (PCR) with hybridization/fluorescent detection. Genotypes of ТР53 gene Arg72Pro polymorphism were identified using PCR-RFLP assay. RESULTS: Eighty-eight percent (90/103) women with CC had HPV, of whom 43.4% (39/90) had HPV type 16, 24.4% (22/90) had HPV type 18, whereas 32.2% (29/90) carried both types. The univariate analysis of allele and genotype distribution of Arg72Pro polymorphic marker of ТР53 gene showed no difference between CC and control groups (χ(2)=1.24, р=0.54). However, when CC cases associated with HPV were tested against controls, Arg72 allele and Arg72Arg genotype prevalence were greater compared to controls (χ²=7.25; р=0.027 for genotypes and χ²=6.83; р=0.009 for alleles). In HPV-positive women, Arg72Arg genotype of ТР53 gene was associated with a 1.85-fold increase in the likelihood of CC (OR=1.85 [95% confidence interval (CI) 1.03-3.32]), whereas Arg72 allele increased this likelihood 1.94-fold (OR=1.94 [95% CI 1.20-3.15]). CONCLUSIONS: Arg72Arg genotype and Arg72 allele of ТР53 gene in Kyrgyz women increase the risk of HPV-associated CC. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC6948899/ /pubmed/31030474 http://dx.doi.org/10.31557/APJCP.2019.20.4.1057 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Isakova, Jainagul
Vinnikov, Denis
Bukuev, Nurbek
Talaibekova, Elnura
Aldasheva, Nazira
ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title_full ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title_fullStr ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title_full_unstemmed ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title_short ТР53 Codon 72 Polymorphism and Human Papilloma Virus-Associated Cervical Cancer in Kyrgyz Women
title_sort тр53 codon 72 polymorphism and human papilloma virus-associated cervical cancer in kyrgyz women
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948899/
https://www.ncbi.nlm.nih.gov/pubmed/31030474
http://dx.doi.org/10.31557/APJCP.2019.20.4.1057
work_keys_str_mv AT isakovajainagul tr53codon72polymorphismandhumanpapillomavirusassociatedcervicalcancerinkyrgyzwomen
AT vinnikovdenis tr53codon72polymorphismandhumanpapillomavirusassociatedcervicalcancerinkyrgyzwomen
AT bukuevnurbek tr53codon72polymorphismandhumanpapillomavirusassociatedcervicalcancerinkyrgyzwomen
AT talaibekovaelnura tr53codon72polymorphismandhumanpapillomavirusassociatedcervicalcancerinkyrgyzwomen
AT aldashevanazira tr53codon72polymorphismandhumanpapillomavirusassociatedcervicalcancerinkyrgyzwomen